| 000 | 01723 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515072038.0 | ||
| 264 | 0 | _c20070809 | |
| 008 | 200708s 0 0 eng d | ||
| 022 | _a0013-9580 | ||
| 024 | 7 |
_a10.1111/j.1528-1167.2007.01128.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSaetre, Erik | |
| 245 | 0 | 0 |
_aAn international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. _h[electronic resource] |
| 260 |
_bEpilepsia _cJul 2007 |
||
| 300 |
_a1292-302 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnticonvulsants _xtherapeutic use |
| 650 | 0 | 4 |
_aCarbamazepine _xadministration & dosage |
| 650 | 0 | 4 | _aCross-Cultural Comparison |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aEpilepsy _xdiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGeriatric Assessment |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLamotrigine |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPatient Dropouts |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTriazines _xtherapeutic use |
| 700 | 1 | _aPerucca, Emilio | |
| 700 | 1 | _aIsojärvi, Jouko | |
| 700 | 1 | _aGjerstad, Leif | |
| 773 | 0 |
_tEpilepsia _gvol. 48 _gno. 7 _gp. 1292-302 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1528-1167.2007.01128.x _zAvailable from publisher's website |
| 999 |
_c17100407 _d17100407 |
||